Search Results - "Borghammer, P"

Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder by Gersel Stokholm, M., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Bacher Svendsen, K., Garrido, A., Vilas, D., Fedorova, T.D., Santamaria, J., Møller, A., Gaig, C., Hiraoka, K., Brooks, D.J., Okamura, N., Borghammer, P., Tolosa, E., Pavese, N.

“…Background and purpose Cholinergic dysfunction appears to play a role in the cognitive impairment observed in Parkinson’s disease and dementia with Lewy…”
Get full text

Olfactory function in Parkinson's Disease - effects of training by Knudsen, K., Flensborg Damholdt, M., Mouridsen, K., Borghammer, P.

“…Background Up to 90% of patients with Parkinson's disease (PD) exhibit olfactory dysfunction, but little is known about the effects of olfactory training. The…”
Get full text

EP-1652: A planning study of dose escalation FET PET active gliomas by IMRT, VMAT and IMPT by Holm, A.I.S, Seiersen, K, Borghammer, P, Petersen, J, Lukacova, S

Get full text

A deformation-based morphometry study of patients with early-stage Parkinson's disease by Borghammer, P., Østergaard, K., Cumming, P., Gjedde, A., Rodell, A., Hall, N., Chakravarty, M. M.

“…Background and purpose:  Previous volumetric magnetic resonance imaging (MRI) studies of Parkinson’s disease (PD) utilized primarily voxel‐based morphometry…”
Get full text

The efficacy of IMRT, VMAT and IMPT to deliver highly conformal FET-PET guided boost in gliomas by Petersen, J.B.B, Holm, A.I.S, Seiersen, K, Borghammer, P, Lukacova, S

Get full text

Improvement of brain tissue oxygenation by inhalation of carbogen by Ashkanian, M, Borghammer, P, Gjedde, A, Østergaard, L, Vafaee, M

“…Abstract Hyperoxic therapy for cerebral ischemia is suspected to reduce cerebral blood flow (CBF), due to the vasoconstrictive effect of oxygen on cerebral…”
Get full text

Combined DaT imaging and olfactory testing for differentiating parkinsonian disorders by Borghammer, P, Knudsen, K, Østergaard, K, Danielsen, E H, Pavese, N, Arveschoug, A, Bluhme, H, Bode, M, Morsing, A

“…Dopamine transporter (DaT) imaging with single photon emission computed tomography (SPECT) detects loss of striatal dopaminergic innervation with very high…”
Get more information

Clinical heterogeneity in Parkinson's disease revisited: a latent profile analysis by Flensborg Damholdt, M., Shevlin, M., Borghammer, P., Larsen, L., Østergaard, K.

“…Objective –  The heterogeneity of Parkinson’s disease (PD) is increasingly recognized, and several attempts have been made to subclassify subjects on clinical…”
Get full text

Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease by Berti, V, Polito, C, Borghammer, P, Ramat, S, Mosconi, L, Vanzi, E, De Cristofaro, M T, De Leon, M, Sorbi, S, Pupi, A

“…Previous positron emission tomography (PET) [18F]fluorodeoxyglucose ([18F]FDG) studies in Parkinson's disease (PD) demonstrated that moderate to late stage…”
Get full text

Effect of memantine on CBF and CMRO2 in patients with early Parkinson's disease by Borghammer, P., Vafaee, M., Ostergaard, K., Rodell, A., Bailey, C., Cumming, P.

“…Objectives –  Parkinson’s disease (PD) may be associated with increased energy metabolism in overactive regions of the basal ganglia. Therefore, we…”
Get full text

Age-related decline of dopamine D2/3 receptor availability measured with [ 11C]raclopride in non-striatal human brain regions: Comparison of four methods by Nomura, Yoshiyuki, Geday, J., Borghammer, P., Vang, K., Chakravarty, M., Gjedde, A.

“…Conclusion The analysis of ROIs and the parametric maps of pB revealed consistent spatial patterns of age-related declines of dopamine D2/3 receptors in…”
Get full text

Prodromal Parkinson disease subtypes — key to understanding heterogeneity by Berg, Daniela, Borghammer, Per, Fereshtehnejad, Seyed-Mohammad, Heinzel, Sebastian, Horsager, Jacob, Schaeffer, Eva, Postuma, Ronald B.

“…In Parkinson disease (PD), pathological processes and neurodegeneration begin long before the cardinal motor symptoms develop and enable clinical diagnosis. In…”
Get full text

Constipation in parkinson's disease: Subjective symptoms, objective markers, and new perspectives by Knudsen, Karoline, Krogh, Klaus, Østergaard, Karen, Borghammer, Per

“…ABSTRACT Constipation is among the first nonmotor symptoms to develop in the prodromal phase of PD. Pathological alpha‐synuclein deposition is present…”
Get full text

171 - The efficacy of IMRT, VMAT and IMPT to deliver highly conformal FET-PET guided boost in gliomas by Petersen, J.B.B., Holm, A.I.S., Seiersen, K., Borghammer, P., Lukacova, S.

Get full text

Brain atrophy in REM sleep behavior disorder is shaped by gene expression and structural connectivity by Rahayel, S., Tremblay, C., Vo, A., Lehéricy, S., Arnulf, I., Vidailhet, M., Corvol, J.-C., Study Group, I., Gagnon, J.-F., Postuma, R., Montplaisir, J., Lewis, S., Matar, E., Ehgoetz Martens, K., Borghammer, P., Knudsen, K., Monchi, O., Misic, B., Dagher, A.

Get full text

Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson's Disease: A Longitudinal Analysis of Two International Cohorts by Leta, Valentina, Urso, Daniele, Batzu, Lucia, Weintraub, Daniel, Titova, Nataliya, Aarsland, Dag, Martinez-Martin, Pablo, Borghammer, Per, van Wamelen, Daniel J, Yousaf, Tayyabah, Rizos, Alexandra, Rodriguez-Blazquez, Carmen, Chung-Faye, Guy, Chaudhuri, K Ray

“…Constipation is regarded as one of the prodromal features of Parkinson's disease (PD) and there is emerging evidence linking gastrointestinal dysfunction and…”
Get more information

Acetylcholinesterase-associated inflammation in patients with giant cell arteritis. Evaluation by histology and 11C-donepezil PET/CT by Therkildsen, Philip, Nielsen, Berit Dalsgaard, Hansen, Ib Tønder, Keller, Kresten Krarup, Steiniche, Torben, Gormsen, Lars Christian, Borghammer, Per, Hauge, Ellen-Margrethe

“…To investigate the in-situ expression of acetylcholinesterase (AChE) in the inflamed vessel wall of patients with biopsy-positive giant cell arteritis (GCA) as…”
Get full text

Engineered antibodies: new possibilities for brain PET? by Sehlin, Dag, Syvänen, Stina

“…Almost 50 million people worldwide are affected by Alzheimer’s disease (AD), the most common neurodegenerative disorder. Development of disease-modifying…”
Get full text

The Parkinsonian Personality and Concomitant Depression by Damholdt, M. F., Ostergaard, K., Borghammer, P., Larsen, L.

“…Parkinson's disease (PD) has been associated with a distinctive parkinsonian personality, characterized by conscientiousness, punctuality, industriousness, and…”
Get full text

Clinical heterogeneity in Parkinson’s disease revisited: a latent profile analysis: Heterogeneity in Parkinson’s disease by Flensborg Damholdt, M., Shevlin, M., Borghammer, P., Larsen, L., Østergaard, K.

Get full text